# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Wilma Mankiller (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML052-SYN-TD
- Date: 1980-07-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rena Hawkfeather-Lindqvist, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Review five weeks after thymectomy. **S**

## History of present illness

Ms. Mankiller returns five weeks after a robotic thymectomy, with two nights in hospital and no postoperative weakness or breathing problem. The pathology showed thymic follicular hyperplasia and no thymoma. The port sites have healed, and she took acetaminophen, not anti-inflammatory medicines, for the pain. Her eyelids have not drooped for three weeks. She raised azathioprine to 100 mg daily after two weeks, as planned, by telephone. The blood tests planned for two, four and six weeks after starting azathioprine were not done: the orders were placed at this clinic, she was preparing for surgery, and no one followed them up. She has had no fever, sore throat, bruising or jaundice. She is back at work three days a week. Home blood pressure readings are about 118/76. **S**

| Element | Detail |
|---|---|
| Thymectomy | Robotic, five weeks ago; no thymoma; uneventful recovery |
| Strength | MG-ADL 2 |
| Azathioprine | 100 mg daily for eight weeks; the early blood tests were missed |
| Work | Three days a week |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Eyes | Negative | No ptosis or double vision for three weeks |
| Respiratory | Negative | No breathlessness; mild ache at the port sites, settling |
| Constitutional | Negative | No fever, sore throat or night sweats |
| Integumentary | Negative | No bruising, jaundice or rash |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |

5 systems reviewed. **S**

## Current medications

- Pyridostigmine bromide 60 mg oral tablet, one tablet four times daily while awake, 30 to 45 minutes before meals **S**
- Prednisone 5 mg oral tablet, tapering from 40 mg each morning by 5 mg every two to three weeks **S**
- Azathioprine 50 mg oral tablet, one tablet daily for two weeks, then two tablets daily, then three tablets (150 mg, about 2.3 mg/kg) daily **S**
- Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet daily with food **S**
- Cholecalciferol (vitamin D3) 1000 units (0.025 mg) oral tablet, one tablet daily **S**
- Sulfamethoxazole 800 mg / trimethoprim 160 mg oral tablet, one tablet three times a week, while prednisone is 20 mg or more with azathioprine **S**
- Acetaminophen 500 mg oral tablet, one or two tablets up to three times daily as needed for leg pain **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/80 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 64.8 kg; BMI 24.4 kg/m². All vital signs are synthetic.

Hemoglobin: 12.6 g/dL; White cell count: 6.2 10*3/uL; Platelets: 250 10*3/uL; Potassium: 4.3 mmol/L; Glucose: 96 mg/dL; Creatinine: 0.79 mg/dL; eGFR (CKD-EPI 1975): 101 mL/min/1.73 m²; ALT: 26 U/L; AST: 24 U/L; Forced vital capacity (seated): 3.4 L; PHQ-2: 0. All results are synthetic.

## Change since baseline

- Hemoglobin: 12.8 g/dL at baseline, 12.6 g/dL at this visit **S**
- White cell count: 6.9 10*3/uL at baseline, 6.2 10*3/uL at this visit **S**
- Platelets: 262 10*3/uL at baseline, 250 10*3/uL at this visit **S**
- Potassium: 4.2 mmol/L at baseline, 4.3 mmol/L at this visit **S**
- Glucose: 88 mg/dL at baseline, 96 mg/dL at this visit **S**
- Creatinine: 0.78 mg/dL at baseline, 0.79 mg/dL at this visit **S**
- eGFR (CKD-EPI 1975): 102 mL/min/1.73 m² at baseline, 101 mL/min/1.73 m² at this visit **S**
- ALT: 18 U/L at baseline, 26 U/L at this visit **S**
- AST: 21 U/L at baseline, 24 U/L at this visit **S**
- Forced vital capacity (seated): 3.3 L at baseline, 3.4 L at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 124/80 mm Hg; weight 64.8 kg |
| Chest | Three healed port sites on the right; lungs clear |
| Eyes | No ptosis after one minute of upgaze |
| Neurological | Neck and limb strength 5 of 5 without fatigue |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Generalized myasthenia gravis after thymectomy** (G70.00). Recovered well from thymectomy; MG-ADL 2. The benefit of thymectomy builds over months to years. **S**
   - Start the prednisone taper: 5 mg less every two to three weeks, toward 7.5 mg or less.
   - Azathioprine 150 mg daily from today.
2. **After thymectomy** (Z90.89). Thymic follicular hyperplasia; no thymoma, so no further oncologic follow-up is needed. **S**
   - No further imaging needed.
3. **Azathioprine monitoring** (Z79.624). White cells 6.2, hemoglobin 12.6, platelets 250, ALT 26 and AST 24: no bone marrow or liver toxicity, but the early checks were missed. **S**
   - Standing laboratory orders at the Cherokee Nation clinic near her home, with a nurse call for each result.
   - Blood count and liver tests two and six weeks after the dose increase, then every three months.
4. **Autosomal dominant polycystic kidney disease** (Q61.2). Creatinine 0.79 mg/dL, eGFR 101; home blood pressure about 118/76; no NSAIDs after surgery. **S**
   - Continue water 2 to 3 liters a day and home readings.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | MG-ADL score | Every visit | Completed today | 2 |
| Imaging | Forced vital capacity | Every visit while on dose changes and after thoracic surgery | Completed today | 3.40 L |
| Examination | Myasthenic crisis warning signs | Every visit | Completed today | None after surgery |
| Laboratory | Blood count on azathioprine | Every one to two weeks for the first two months, then every three months | Completed today | Hemoglobin 12.6 g/dL; white cells 6.2; platelets 250 |
| Laboratory | Liver tests, creatinine, potassium and glucose | With each blood count on azathioprine; potassium on trimethoprim-sulfamethoxazole | Completed today | ALT 26 and AST 24 U/L; creatinine 0.79 mg/dL; eGFR 101; potassium 4.3 mmol/L; glucose 96 mg/dL |
| Laboratory | Early azathioprine blood tests missed | Two, four and six weeks after starting | Deferred | Not done, a deviation from the protocol: the orders were placed here, she was preparing for surgery an hour's drive away, and no one followed up. Today's tests at ten weeks show no toxicity, so no harm resulted, but a low white count could have gone unnoticed. Corrective action: standing orders at the Cherokee Nation clinic near her home, with a nurse call for each result |
| Examination | Blood pressure and weight | Every visit | Completed today | 124/80 mm Hg; home about 118/76; weight 64.8 kg |
| Medication safety | Pneumocystis prophylaxis | While prednisone is 20 mg or more with azathioprine | Completed today | Continues; potassium 4.3 mmol/L |
| Medication safety | Glucocorticoid effects | Every visit | Completed today | Sleep shorter; weight up 3 kg since diagnosis; no infection |
| Survey | Depression screen (PHQ-2) | At intervals | Completed today | PHQ-2 score 0 |
| Referral | Thymectomy | Once | Completed today | Done five weeks ago; no thymoma |
| Self-management | Laboratory access close to home | Each blood test | Completed today | Standing orders placed at the Cherokee Nation clinic |

## Goal progress

- A confirmed diagnosis and treatment plan within three weeks. Outcome by 1980-03-23: AChR antibodies, nerve stimulation, chest CT and kidney ultrasound done; generalized MG diagnosed and treatment begun at two weeks. **S**
- Minimal manifestation status (MG-ADL 0 to 1) within a year, with prednisone at 7.5 mg or less. In progress; target 1980-10-12. **S**
- No myasthenic crisis, and she knows the warning signs and the medicines to avoid. In progress; target 1980-10-12. **S**
- Kidney health: eGFR and urine albumin yearly, home blood pressure 110/75 mm Hg or lower if it rises above 130/85, 2 to 3 liters of water a day, and no NSAIDs. In progress; target 1980-10-12. **S**
- Return to full-time work for the Cherokee Nation. In progress; target 1980-10-12. **S**

## Medication changes

- Stopped: Prednisone 10 mg oral tablet, 10 mg each morning, rising by 10 mg each week to 40 mg each morning, then held at 40 mg **S**
- Started: Prednisone 5 mg oral tablet, tapering from 40 mg each morning by 5 mg every two to three weeks **S**

## Guideline basis

- Narayanaswami P, et al. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology 2021;96(3):114-122 (2020), Myasthenia Gravis Foundation of America task force (Neurology)
- Sanders DB, et al. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology 2016;87(4):419-425 (2016), Myasthenia Gravis Foundation of America task force (Neurology)
- Wolfe GI, et al. Randomized Trial of Thymectomy in Myasthenia Gravis (MGTX). N Engl J Med 2016;375(6):511-522 (2016), New England Journal of Medicine
- KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int 2025;107(2S):S1-S239 (2025), Kidney Disease: Improving Global Outcomes (KDIGO)

## Follow-up

- Blood count and liver tests at the Cherokee Nation clinic in two and six weeks. Preventive visit in six weeks. Review here in three months. **S**
- Next scheduled visit 1980-08-24: periodic adult preventive visit. **S**
